1438 Metformin Hydrochloride 500mg (Sustained Release), Glimepiride 2mg and Voglibose 0.2mg Tablets

1438 Metformin Hydrochloride 500mg (Sustained Release), Glimepiride 2mg and Voglibose 0.2mg Tablets combine three powerful agents to help manage blood sugar levels in people with type 2 diabetes. Designed for effective glycemic control, this formulation provides sustained release of Metformin for prolonged effect, Glimepiride for enhanced insulin secretion, and Voglibose for reduced postprandial glucose spikes. Ideal as a comprehensive treatment option prescribed by your healthcare professional.